Skip to content
Open access

Cryptotanshinone and 15,16-dihydrotanshinone I from Salvia miltiorrhiza: integrated in vitro and computational evaluation of their antidiabetic potential

Sep 2026 · RSC Advances · 0 citations · 45 references
Medicine

TL;DR

Overall, compound 2 exhibited the stronger experimentally measured yeast α-glucosidase inhibition, whereas the computational findings provide target-specific hypotheses rather than confirming multitarget antidiabetic activity.

Abstract

Salvia miltiorrhiza Bunge (Lamiaceae) is a traditional medicinal plant rich in bioactive tanshinones with diverse pharmacological properties. However, comparative information regarding experimentally measured activity and computational interaction profiles of individual tanshinones remains limited. This study aimed to compare cryptotanshinone (1) and 15,16-dihydrotanshinone I (2), isolated from S. miltiorrhiza, using an integrated in vitro and computational approach. The compounds were obtained through activity-informed phytochemical fractionation and evaluated for inhibition of α-glucosidase at 3, 10, and 30 µM. Concentration-response data were analyzed by nonlinear regression. Their computational interaction profiles were further investigated by molecular docking against selected diabetes-related proteins, followed by molecular dynamics simulations, MM/GBSA calculations, and in silico ADMET/toxicity predictions. Compound 2 showed stronger yeast α-glucosidase inhibition than compound 1, with IC50 values of 7.76 µM (95% CI: 7.43–8.10 µM) and 10.64 µM (95% CI: 9.62–11.77 µM), respectively (p < 0.0001). In contrast, the docking preferences were target dependent: compound 1 produced more negative docking scores for human MGAM-C, PTP1B, and glucokinase, whereas compound 2 ranked more favorably for GSK-3β, NLRP3, PPAR-γ, and GLP-1R. This lack of concordance between yeast α-glucosidase inhibition and human MGAM-C docking indicates that docking rankings should not be interpreted as direct evidence of target inhibition. Molecular dynamics simulations revealed target- and ligand-dependent binding behavior, while MM/GBSA calculations yielded negative estimated binding free energies for the investigated complexes. Although both compounds satisfied Lipinski's rule, the predicted low gastrointestinal absorption, extensive plasma protein binding, CYP inhibition, and toxicity alerts indicated important developability limitations. Overall, compound 2 exhibited the stronger experimentally measured yeast α-glucosidase inhibition, whereas the computational findings provide target-specific hypotheses rather than confirming multitarget antidiabetic activity. Further studies using purified human enzymes, mechanistic assays, experimental pharmacokinetic and toxicological evaluations, and in vivo models are required to establish their biological and therapeutic relevance.

Read PDF

Similar papers

Aug 2026

Benzylisoquinoline Alkaloids from NelumbinisPlumula as Potential Butyrylcholinesterase Inhibitors: Isolation, Characterization and Bioactivity Evaluation.

Nelumbinis Plumula is a well-known traditional herb with medicinal and edible homology, which is commonly consumed as tea to clear heart-fire, calm the mind and improve sleep in daily life. A systematic phytochemical investigation on the extract of Nelumbinis Plumula was carried out, leading to the isolation of ten new...

Wen-Jun Wei, Dong-Ge Wang, Ji-Gao Yang et al. · 0 citations
Open access Oct 2026

New benzylresorcinol and benzylstilbene derivatives from the fruits of orchid Galeola nudifolia Lour. with anti-neuroinflammatory activity

Galeola nudifolia is a medicinal orchid recognized as a valuable source of structurally diverse natural products with potential therapeutic applications. Its chemical composition and biological activities remain largely unexplored, particularly with respect to anti-neuroinflammatory activity. Bioassay-guided investigat...

D. Tran, Bien-Thuy Bui Nguyen, Yuh-Chiang Shen et al. · 0 citations
Open access Oct 2026

Phytochemical profiling and bioactivity of Rhaponticoides mykalea: α-glucosidase inhibition, apoptosis-associated cytotoxicity, and in silico molecular insights.

BACKGROUND Rhaponticoides mykalea is an endemic species with limited data on its phytochemistry and biological activity. The aqueous ethanol extract (700 mL L-1, v/v) of the aerial parts and its n-hexane, ethyl acetate (RPEtAc), n-butanol, and water fractions were evaluated for enzyme inhibition, antioxidant activity,...

L. Paşayeva, Miray Ersoy, Hanifa Fatullayev et al. · 0 citations
Open access Oct 2026

Homoisoflavanones, Alkaloid, and Norsesquiterpenoid from Polygonatum cyrtonema and Their Immunomodulatory Effects

Polygonatum cyrtonema (Huang jing) is widely used in both the food and traditional Chinese medicine industries. A chemical investigation of the rhizome of cultivated P. cyrtonema yielded six previously undescribed compounds─one norsesquiterpenoid (1), one pyridine alkaloid (2), and four homoisoflavanones (3a, 4a, 5a,...

Hong-Su Zhao, Cai-Xia Lu, Fu-Cai Ren et al. · 0 citations
Open access Sep 2026

A New Flavonoid Glycoside from the Stem Bark of Albizia saponaria: Isolation, Structural Elucidation, and In Silico Evaluation as a Potent α-Glucosidase Inhibitor

P predictive findings establish Compound 1 as a highly promising, low-toxicity natural scaffold for anti-hyperglycemic drug development and warrants subsequent in vitro and in vivo functional validation.

E. J. Pongoh, R. Rumampuk · 0 citations
Open access Aug 2026

Evaluation of Inhibitory Activities of Phenolic and Flavonoid Constituents of Nelumbo nucifera Gaertn. Against Tyrosinase, Elastase, and Collagenase by Computational Methods and Supported by Experimental Validation

Nelumbo nucifera Gaertn. is a rich source of bioactive compounds, and has been extensively investigated for its antioxidant and anti-inflammatory properties. However, despite its broad pharmacological potential, detailed molecular-level insights into the interactions of its phenolic and flavonoid constituents with key...

Ployvadee Sripadung, Nadtanet Nunthaboot, C. Mekjaruskul et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.